苯并γ-吡喃酮类 PDE10A 抑制剂的设计、合成及初步生物活性评价

吴伟俊 ,  何家静 ,  吴俊鹏 ,  蓝坤燕 ,  吴峥

高等学校化学学报 ›› 2026, Vol. 47 ›› Issue (11) : 72 -79.

PDF (2079KB)
高等学校化学学报 ›› 2026, Vol. 47 ›› Issue (11) : 72 -79. DOI: 10.7503/cjcu20260158
研究论文

苯并γ-吡喃酮类 PDE10A 抑制剂的设计、合成及初步生物活性评价

作者信息 +

Design, Synthesis and Preliminary Biological Evaluation of Chromone-based PDE10A Inhibitors

Author information +
文章历史 +
PDF (2128K)

摘要

基于对PDE10A蛋白结构及其现有抑制剂相互作用模式的综合分析, 采用拼合原理, 设计合成了10个全新的PDE10A抑制剂. 活性测试结果显示, 除化合物A4和A5外, 其余化合物均表现出不同程度的抑制活性(半数抑制浓度IC50=38.83~98.83 nmol/L). 对活性最佳的化合物A1, A2和A9进行了分子对接研究, 发现均能嵌入PDE10A蛋白PHE729与ILE692/PHE696形成的疏水夹层中, 其通过 π-π堆积和氢键发挥抑制作用. ADMET预测结果显示, 这3个化合物具有良好的肠道吸收性、 低血脑屏障透过率及较低的毒性, 具备进一步开发为先导化合物的潜力.

Abstract

Based on the comprehensive analysis of the PDE10A protein structure and the interaction patterns of existing inhibitors, using the hybrid principle, ten new PDE10A inhibitors were designed and synthesized. The activity test results showed that except for compounds A4 and A5, the remaining compounds all exhibited varying degrees of inhibitory activity(IC50=38.83-98.83 nmol/L). The most active compounds A1, A2, and A9 were selected for molecular docking, and it was found that they could all insert into the hydrophobic layer formed by PHE729 and ILE692/PHE696 in the PDE10A protein, exerting inhibitory effects through π-π stacking and hydrogen bonds. The ADMET prediction results indicated that these three compounds had good intestinal absorption properties, low blood-brain barrier permeability, and low toxicity, and had the potential to be further developed as lead compounds.

关键词

苯并γ-吡喃酮 / PDE10A抑制剂 / 分子对接 / ADMET预测

Key words

Chromone / PDE10A inhibitor / Molecular docking / ADMET prediction

引用本文

引用格式 ▾
吴伟俊,何家静,吴俊鹏,蓝坤燕,吴峥. 苯并γ-吡喃酮类 PDE10A 抑制剂的设计、合成及初步生物活性评价[J]. 高等学校化学学报, 2026, 47(11): 72-79 DOI:10.7503/cjcu20260158

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Alnazari M., Bakhsh A., Abdullah S., Al Qahtani S., Borhan W., Rajih E., Alshehri A. M., Medicine(Baltimore), 2026, 105(10), e47683

[2]

Kelly E. D., Ranek M. J., Zhang M. L., Kass D. A., Muller G. K., Annu. Rev. Pharmacol. Toxicol., 2025, 65, 415-441

[3]

Barnes H., Brown Z., Burns A., Williams T., Cochrane Database Syst. Rev., 2019, 31(1), CD012621

[4]

Sadeghi M. A., Nassireslami E., Zoshk M. Y., Hosseini Y., Abbasian K., Chamanara M., Psychopharmacology, 2023, 240(6), 1201-1219

[5]

Zagórska A., Expert Opin. Ther. Pat., 2020, 30(2), 147-157

[6]

Kamel R., Leroy J., Vandecasteele G., Fischmeister R., Nat. Rev. Cardiol., 2023, 20(2), 90-108

[7]

Barthou A., Kamel R., Leroy J., Vandecasteele G., Fischmeister R., Med. Sci.(Paris), 2024, 40(6/7), 534-543

[8]

Howes O. D., Bukala B. R., Beck K., Nat. Rev. Neurol., 2024, 20(1), 22-35

[9]

Kubota M., Takahata K., Matsuoka K., Sano Y., Yamamoto Y., Tagai K., Tarumi R., Suzuki H., Kurose S., Nakajima S., Shiwaku H., Seki C., Kawamura K., Zhang M. R., Takahashi H., Takado Y., Higuchi M., Schizophr. Bull., 2023, 49(3), 688-696

[10]

Tejeda G. S., Whiteley E. L., Deeb T. Z., Bürli R. W., Moss S. J., Sheridan E., Brandon N. J., Baillie G. S., Proc. Natl. Acad. Sci. USA, 2020, 117(1), 677-688

[11]

Ghoflchi S., Nakhaei A., Abbasinezhad-Moud F., Jalili-Nik M., Cimino P. J., Front. Oncol., 2025, 15, 1669157

[12]

Nuechterlein N., Shelbourn A., Szulzewsky F., Arora S., Casad M., Pattwell S., Merino-Galan L., Sulman E., Arowa S., Alvinez N., Jung M., Brown D., Tang K., Jackson S., Stoica S., Chittaboina P., Banasavadi-Siddegowda Y. K., Wirsching H. G., Stella N., Shapiro L., Paddison P., Patel A. P., Gilbert M. R., Abdullaev Z., Aldape K., Pratt D., Holland E. C., Cimino P. J., Genes Dev., 2024, 38(5/6), 273-288

[13]

Chen S., Fan X. Y., Xu S. M., Zhu N. C., Shi H. C., Jin Z. G., Yan C., Circulation, 2025, 152(19), 1371-1392

[14]

Chappie T. A., Helal C. J., Hou X. J., J. Med. Chem., 2012, 55(17), 7299-7331

[15]

Hu E., Chen N., Bourbeau M. P., Harrington P. E., Biswas K., Kunz R. K., Andrews K. L., Chmait S., Zhao X. N., Davis C., Ma J., Shi J. X., Lester-Zeiner D., Danao J., Able J., Cueva M., Talreja S., Kornecook T., Chen H., Porter A., Hungate R., Treanor J., Allen J. R., J. Med. Chem., 2014, 57(15), 6632-6641

[16]

Yu Y. F., Zhang C., Huang Y. Y., Zhang S. R., Zhou Q., Li X. M., Lai Z. W., Li Z., Gao Y. Q., Wu Y. N., Guo L., Wu D. Y., Luo H. B., ACS Chem. Neurosci., 2020, 11(7), 1058-1071

[17]

Huang H. Z., Xue H. X., Cai A. Q., Yuan H., Yao Y. F., Liu R. D., Yang Y., Wang Q., Li Z., Liu T., Huang Y. Y., Dai W., Luo H. B., Zou X. Z., Wang X. Y., Guo L., Eur. J. Med. Chem., 2025, 290, 117537

[18]

Verhoest P. R., Chapin D. S., Corman M., Fonseca K., Harms J. F., Hou X. J., Marr E. S., Menniti F. S., Nelson F., O’Connor R., Pandit J., Proulx-Lafrance C., Schmidt A. W., Schmidt C. J., Suiciak J. A., Liras S., J. Med. Chem., 2009, 52(16), 5188-5196

[19]

Yin S. Q., Zheng Z. G., He X. T., Wang S. M., Gu X. G., Wang E. J., Chem. J. Chinese Universities, 2026, 47(5), 20260042

[20]

(尹诗琪, 郑志刚, 何心桐, 王世敏, 顾星桂, 王二静. 高等学校化学学报, 2026, 47(5), 20260042)

[21]

Gaspar A., Garrido E. M. P. J., Borges F., Garrido J. M. P. J., ACS Omega, 2024, 9(20), 21706-21726

[22]

Duan Y. D., Jiang Y. Y., Guo F. X., Chen L. X., Xu L. L., Zhang W., Liu B., Fitoterapia, 2019, 135, 114-129

[23]

Neha D. M., Nandkishor D. G., Mahendra N. L., Santosh J. U., Manisha M. K., Results Chem., 2023, 6, 101139

[24]

Mills S. D., Eakin A. E., Buurman E. T., Newman J. V., Gao N., Huynh H., Johnson K. D., Lahiri S., Shapiro A. B., Walkup G. K., Yang W., Stokes S. S., Antimicrob. Agents Chemother., 2011, 55(3), 1088-1096

[25]

Seeliger D., de Groot B. L., J. Comput. Aid. Mol. Des., 2010, 24(5), 417-422

[26]

Morris G. M., Huey R., Olson A. J., Curr. Protoc. Bioinformatics, 2008, 8(S24), 14

[27]

Li F. C., Li W. X., He S. F., Chen Y. K., Zhou H., Zhou H. F., Liu Q. X., Tian L. Y., Chem. J. Chinese Universities, 2026, 47(2), 20250257

[28]

(李馥莼, 李文歆, 何姝芳, 陈毅昆, 周皓, 周海峰, 刘祈星, 田峦鸢. 高等学校化学学报, 2026, 47(2), 20250257)

[29]

Fu L., Shi S. H., Yi J. C., Wang N. N., He Y. H., Wu Z. X., Peng J. F., Deng Y. C., Wang W. X., Wu C. K., Lyu A., Zeng X. X., Zhao W. T., Hou T. J., Cao D. S., Nucleic Acids Res., 2024, 52(W1), W422-W431

[30]

Shinde S. S., Giram P. S., Wakte P. S., Bhusari S. S., Adv. Pharmacol., 2025, 103, 65-80

基金资助

国家自然科学基金(82260671)

AI Summary AI Mindmap
PDF (2079KB)

2

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉